摘要
目的探讨Glubran（NBCA-MS）胶栓塞脑动静脉畸形的临床技巧及治疗效果。方法在DSA监测下对96例脑动静脉畸形患者采用不同浓度的意大利GEM公司生产的Glubran（NBCA-MS）胶进行187次血管内栓塞治疗．并对患者进行跟踪随访．了解临床效果。结果96例患者中临床随访92例未再出现临床症状．症状好转3例．复发1例。48例行脑血管造影复查，其中44例畸形血管团完全消失，其余栓塞程度达80％～90％以上，进一步行γ-刀放射治疗。本组共32例栓塞后行γ-刀放射治疗，其中26例患者治疗1～2年后行DSA造影检查，21例畸形血管团完全消失。结论用Glubran（NBCA．MS）胶血管内栓塞治疗脑动静脉畸形是一种安全、有效的治疗手段。
Objective To explore the clinical skills and curative efficacy of Glubran （NBCA-MS） embolization of cerebral arteriovenous malformations. Methods Ninety-six cases of cerebral arteriovenous malformations were treated by 187 endovascular embolizations with different concentrations of Italy GEM company＇ s Glubran CNBCA-MS）. Follow-up was performed to 96 cases of cerebral arteriovenous malformation with NBCA-MS embolization. Results During the follow-up in 96 cases, clinical symptoms completely disappeared in 92, were improved in 3 and reoccurred in 1. The malformation was totally got rid of in 44 of 48 cases DSA examinated, and the 80%-90% embolization was achieved in the rest who need further ^-knife therapy. In all cases, γ-knife therapy was performed in 32 cases after embolization, and among them 26 cases received DSA examination 1-2 years after γ-knife therapy, and 21 cases were proved to have no malformation. Conclusions The method of endovascular emdolization with NBCA-MS is safe, reliable and effective to treat the cerebral arteriovenous malformation.
出处
《中华神经医学杂志》
CAS
CSCD
2008年第5期487-490,共4页
Chinese Journal of Neuromedicine
